BREAKOUT STOCK ALERT UPDATE
INO - Inovio Pharmaceuticals, Inc. - Common Stock
Initial Alert Price: $9.69
Price High: $19
% Gains/Losses: 96.08%
(+74.02% More Than Expected)
Potential Stop Loss: $18.05
INO hit $19.74 in today's premarket session after the company announced that it was awarded the US Patent for their oral device and use of thereof providing us with a 103.72% Return on Our Initial Investment from Jan. 19th, 2021. The stock consolidated and found support on the $13.83 Price Level before bouncing back and closing around the $14.87 Prices Levels. When the stock dropped from the $19.00 Price Range, we saw large sells volume spikes but it seemed to lower as the trading session continue and we have not seen too much sells volume to close this trade out yet. We are currently looking for signals for a continue moved to the upside moving forward and will be watching this stock going into tomorrow's trading sessions. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
INO - Inovio Pharmaceuticals, Inc. - Common StockInitial Alert Price: $9.69
Price High: $19
% Gains/Losses: 96.08%
(+74.02% More Than Expected)
Potential Stop Loss: $18.05
INO hit $19.74 in today's premarket session after the company announced that it was awarded the US Patent for their oral device and use of thereof providing us with a 103.72% Return on Our Initial Investment from Jan. 19th, 2021. The stock consolidated and found support on the $13.83 Price Level before bouncing back and closing around the $14.87 Prices Levels. When the stock dropped from the $19.00 Price Range, we saw large sells volume spikes but it seemed to lower as the trading session continue and we have not seen too much sells volume to close this trade out yet. We are currently looking for signals for a continue moved to the upside moving forward and will be watching this stock going into tomorrow's trading sessions. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.